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Introduction
Despite the fact that NDPH has been considered one of
the most refractory headaches, there are limited data avail-
able regarding the clinical characteristics, pharmacological
treatment and prognosis of NDPH.
Purpose
To discuss cases which were identified as NDPH by the
International Headache Society diagnostic criteria.
Methods
Our NDPH patients consisted of 8 females and 3 males,
with an onset age ranging from 15 to 72 years old. The
duration of the headaches, location, intensity and nature
of the pain, precipitating factors and treatments were
investigated.
Results
The duration of the headaches ranged from 9 months to
24 years. Pain was diffuse in 3 patients, occipital-neck area
in 4, frontal in 1 and left-sided in 1. Pain intensity was
mild in 1 case, mild to moderate in 2, moderate in 7 and
moderate to severe in 1. The nature of the pain was more
similar to a chronic tension-type headache (73%) than a
migraine-type, although 4 cases were found to be throb-
bing in nature. Headaches were related to stressful life
events in 2 patients and exercise in 1 case. While two of
the patients had received stellate ganglion blocks, all
patients had received several kinds of drugs including
analgesics, muscle relaxants, tricyclic antidepressants,
selective serotonin reuptake inhibitors, anti-anxiety agents
and anti-epileptic drugs. Nine patients were refractory to
the pharmacological treatments.
Conclusion
Despite the general tendency that the pain of NDPH is
dull, patients occasionally suffer from bouts of throbbing
pain. NDPH is the refractory headache and requires
optimal pharmacological regimens on an individual basis.
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